Intel Lobbies For Home-Based Medical Technology
This article was originally published in The Gray Sheet
Executive Summary
Many members of Congress working on health care reform do not appreciate the full potential of technology to make the U.S. health care system more cost-effective, according Eric Dishman, director of Health Innovation and Policy for Intel's Digital Health Group
You may also be interested in...
Intel’s First Home-Monitor Device Clears FDA, Will Launch This Year
Computer chip giant Intel expects to get into the U.S. medical device market later this year with the Health Guide home chronic condition management tool
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.